Search

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://journals.physiology.org/doi/full/10.1152/japplphysiol.00303.2019?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org This is the pre-peer reviewed version of the following article: Almendros, I., Martínez-Ros, P., Farré, N., Rubio-Zaragoza, M., Torres, M., Gutiérrez-Bautista, A.J. et al. (2019). Placental oxygen transfer reduces hypoxia-reoxygenation swings in fetal blood in a sheep model of gestational sleep apnea. Journal of Applied Physiology, vol. 127, i. 3 (13 sep.), pp. 745-752, which has been published in final form at https://doi.org/10.1152/japplphysiol.00303.2019. Este es el pre-print del siguiente artículo: Almendros, I., Martínez-Ros, P., Farré, N., Rubio-Zaragoza, M., Torres, M., Gutiérrez-Bautista, A.J. et al. (2019). Placental oxygen transfer reduces hypoxia-reoxygenation swings in fetal blood in a sheep model of gestational sleep apnea. Journal of Applied Physiology, vol. 127, i. 3 (13 sep.), pp. 745-752, que se ha publicado de forma definitiva en https://doi.org/10.1152/japplphysiol.00303.2019. AIM: Obstructive sleep apnea (OSA), characterized by events of hypoxia reoxygenation, is highly prevalent in pregnancy, negatively affecting the gestation process and particularly the fetus. Whether the consequences of OSA on the fetus and offspring are mainly caused by systemic alterations in the mother or by direct effect of intermittent hypoxia in the fetus is unknown. In fact, how apnea-induced hypoxemic swings in OSA are transmitted across the placenta remains to be investigated. The aim of this study was to test the hypothesis, based on a theoretical background on the dampening effect of oxygen transfer in the placenta, that oxygen partial pressure (PO2) swings resulting from obstructive apneas mimicking OSA are mitigated in the fetal circulation. METHODS: To this end, 4 anesthetized ewes close to term pregnancy were subjected to obstructive apneas consisting of 25-s airway obstructions. Real time PO2 was measured in the maternal carotid artery and in the umbilical vein using fast-response fiberoptic oxygen sensors. RESULTS: The amplitude of PO2 swings in the umbilical vein were considerably smaller (3.1±1.0 vs. 21.0±6.1 mmHg (m±SE); p

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.mdpi.com/2079-4983/9/1/10 The overall increase of chronic degenerative diseases associated with ageing makes wound care a tremendous socioeconomic burden. Thus, there is a growing need to develop novel wound healing therapies to improve cutaneous wound healing. The use of regenerative therapies is becoming increasingly popular due to the low-invasive procedures needed to apply them. Platelet-rich plasma (PRP) is gaining interest due to its potential to stimulate and accelerate the wound healing process. The cytokines and growth factors forming PRP play a crucial role in the healing process. This article reviews the emerging field of skin wound regenerative therapies with particular emphasis on PRP and the role of growth factors in the wound healing process.

Esta es la versión pre-print del artículo que se encuentra disponible en la página web de la revista en la siguiente URL: https://link.springer.com/article/10.1007/s00167-015-3725-2 To assess the biomechanical effects of intra-tendinous injections of PRGF on the healing Achilles tendon after repair in a sheep model. Thirty sheep were randomly assigned into one of the six groups depending on the type of treatment 10 received (PRGF or placebo) and survival time (2, 4 and 8 weeks). The Achilles tendon injury was repaired by suturing the tendinous edges employing a three-loop pulley pattern. A trans-articular external fixation system was then used for immobilization. The PRGF or placebo was administered on a weekly basis completing a maximum of 3 infiltrations. The force, section and tension values were compared between the operated and healthy Achilles tendons across all groups. The PRGF-treated tendons had higher force at eight weeks compared with the placebo group (p=0.007). Between two and four weeks, a significant increase in force in both the PRGF-treated tendon (p=0.0027) and placebo group (p=0.0095) occurred. No significant differences were found for section ratio between PRGF-treated tendons and the placebo group for any of the time periods evaluated. At 2 weeks PRGF-treated tendons had higher tension ratio compared to placebo group tendons (p=0.0143). Both PRGF and placebo treatments significantly improved the force (p